Genmab A/S

Genmab is a Danish biotechnology company that develops antibody-based medicines to treat cancer and other diseases. The company has several drugs on the market, including EPKINLY and TEPKINLY for certain types of lymphoma, Tivdak for cervical cancer, and DARZALEX for multiple myeloma. Genmab also has a pipeline of experimental drugs in development for various cancers, blood disorders, and other conditions, and collaborates with major pharmaceutical companies like Pfizer, Johnson & Johnson, and Amgen.